Journal Article

Process intensification for the production of rituximab by an inducible CHO cell line

Perrier, Michel, Ansorge, Sven, Henry, Olivier, Brochu, Denis, Gilbert, Michel, Durocher, Yves, Mellahi, Kahina

2019

Overview

Mammalian-inducible expression systems are increasingly available and offer an attractive platform for the production of recombinant proteins. In this work, we have conducted process development for a cumate-inducible GS-CHO cell-line-expressing rituximab. To cope with the limitations encountered in batch when inducing at high cell densities, we have explored the use of fed-batch, sequential medium replacements, and continuous perfusion strategies applied during the pre-induction (growth) phase to enhance process performance in terms of product yield and quality. In shake flask, a fed-batch mode and a complete medium exchange at the time of induction were shown to significantly increase the integral of viable cell concentration and antibody titer compared to batch culture. Further enhancement of product yield was achieved by combining bolus concentrated feed additions with sequential medium replacement, but product galactosylation was reduced compared to fed-batch mode, as a result of the extended culture duration. In bioreactor, combining continuous perfusion of the basal medium with bolus daily feeding during the pre-induction period and harvesting earlier during the production phase is shown to provide a good trade-off between antibody titer and product galactosylation. Overall, our results demonstrate the importance of selecting a suitable operating mode and harvest time when carrying out high-cell-density induction to balance between culture productivity and product quality.

• Publisher: Springer Nature B.V
• Subject: Batch culture / Bioreactors / Cell culture / Cell density / Harvesting / Immunotherapy / Monoclonal antibodies / Perfusion / Process intensification / Proteins / Rituximab